Jill Hauer

Title(s)Postdoctoral Scholar, Cellular and Molecular Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Defining Nephritic Factors as Diverse Drivers of Systemic Complement Dysregulation in C3 Glomerulopathy. Kidney Int Rep. 2024 Feb; 9(2):464-477. Hauer JJ, Zhang Y, Goodfellow R, Taylor A, Meyer NC, Roberts S, Shao D, Fergus L, Borsa NG, Hall M, Nester CM, Smith RJH. PMID: 38344720; PMCID: PMC10851021.
      View in: PubMed   Mentions:
    2. C3 glomerulopathy: Understanding an ultra-rare complement-mediated renal disease. Am J Med Genet C Semin Med Genet. 2022 Sep; 190(3):344-357. Heiderscheit AK, Hauer JJ, Smith RJH. PMID: 35734939; PMCID: PMC9613507.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    3. Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy. Kidney Int. 2022 10; 102(4):904-916. Chauvet S, Hauer JJ, Petitprez F, Rabant M, Martins PV, Baudouin V, Delmas Y, Jourde-Chiche N, Cez A, Ribes D, Cloarec S, Servais A, Zaidan M, Daugas E, Delahousse M, Wynckel A, Ryckewaert A, Sellier-Leclerc AL, Boyer O, Thervet E, Karras A, Smith RJH, Frémeaux-Bacchi V. PMID: 35752323; PMCID: PMC10588728.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    4. Factor B and C4b2a Autoantibodies in C3 Glomerulopathy. Front Immunol. 2019; 10:668. Hauer JJ, Shao D, Zhang Y, Nester CM, Smith RJH. PMID: 31024533; PMCID: PMC6460050.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies. J Am Soc Nephrol. 2016 Apr; 27(4):1245-53. Bu F, Borsa NG, Jones MB, Takanami E, Nishimura C, Hauer JJ, Azaiez H, Black-Ziegelbein EA, Meyer NC, Kolbe DL, Li Y, Frees K, Schnieders MJ, Thomas C, Nester C, Smith RJ. PMID: 26283675; PMCID: PMC4814193.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans